Navigation Links
BioStorage Technologies, Inc. to Hold Global Sample Management Benchmarking Symposium in Conjunction With 2011 IIR Biorepositories Conference
Date:9/7/2011

INDIANAPOLIS, Sept. 7, 2011 /PRNewswire/ -- BioStorage Technologies, a global leader in scientific asset management, biomaterial storage and cold chain logistics, will host its third in a series of four Global Sample Management Benchmarking Symposia in conjunction with the 4th annual Biorepositories Conference on Sept. 19, 2011 in Boston. Featuring presentations from a diverse panel of multidisciplinary professionals and experts within the biobanking community, the symposium will examine strategies for outsourced and onsite management of biospecimen samples.  

"Biospecimen samples are critical scientific assets important to supporting today's research efforts, as well as validating future findings and advancing the development of novel therapies," said Gregory Swanberg, Chief Executive Officer, BioStorage Technologies. "BioStorage Technologies has been a strong supporter of the Biorepositories Conference since its inception four years ago, and holding our Global Sample Management Benchmarking in conjunction with such an impressive event was a natural fit for us."

The symposium will provide insight into trends, challenges and regulatory mandates affecting global biorepository operations, including: the emerging need for samples in specific disease areas, best practices for managing global patient consent of sample assets, onsite virtual management of sample inventories and regulatory concerns for sample management in China.

The robust speaker line up includes:

  • Dr. John Bloom, President, Bloom Consulting Services, LLC and Special Government Employee to the FDA
    "Emerging Needs in the use of Biorepositories for Drug Development: Implications for Targeted Disease Therapies and Sample Asset Management"
  • Dr. Karina Bienfait, Clinical Pharmacogenomics Operations Lead in Clinical Pharmacogenomics and Clinical Specimen Management, Merck & Company
    "Best Practices in the Management of Patient Informed Consent"
  • Steve Sweeney, Head of Clinical Technologies, Infinity Pharmaceuticals, Inc.
    "Strategies for Improving the Onsite Management of Scientific Sample Assets"
  • Suzanne M. O'Shea, Legal Counsel, Baker and Daniels LLP and former Regulatory Counsel to the U.S. Food and Drug Administration
    "Understanding How to Navigate the Regulatory Environment When Managing Samples in China"

BioStorage Technologies is also a platinum sponsor of the Biorepositories Conference, and will host several workshops at the event. Lori Ball, Chief Operating Officer, BioStorage Technologies, will co-present a workshop titled, "Manage your Biorepository to Guarantee Full Life-Cycle Specimen Quality" and Catherine Michael, Sr. Director, Comprehensive Solutions, BioStorage Technologies, will give a presentation titled, "Incorporate Quality-Control Methodologies to Identify, Control, and Eliminate Threats to Specimen Longevity and Stability."

For more information on the Global Sample Management Benchmarking Symposium, visit www.biostorage.com.

About BioStorage Technologies, Inc.:

BioStorage Technologies, Inc. is the premier, global provider of comprehensive sample management solutions for the bioscience industry. Offering onsite or outsourced management of sample assets, BioStorage Technologies manages the complete life-cycle of samples. With a team of global sample experts, state-of-the-art temperature-controlled storage facilities, and a real-time, web-based sample intelligence and tracking system, the company supports customers in maximizing opportunities, minimizing risk and reducing the cost of sample management. BioStorage Technologies, Inc. is privately held and headquartered in Indianapolis with an additional full-service site near Frankfurt, Germany. For more information, visit www.biostorage.com or call +1 (866) 697-2675 or +49-6155-898-1011.

Press Contact:
Michael Clark
Miller Brooks, Inc.
317-873-8100
michael@millerbrooks.com


'/>"/>
SOURCE BioStorage Technologies, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. BioStorage Technologies Showcases First-Ever Mobile Biorepository - Relofleet™ at Drug Information Association Annual Meeting
2. BioStorage Technologies Expands U.S. Operations with Opening of New Biorepository Facility
3. BioStorage Technologies Appoints New Director of Business Development for European Operations
4. AMDeCs Vendor Program Expands Focus with Addition of BioStorage Technologies, Offering Preferred Pricing on Tissue Storage and Cold Chain Logistics Services
5. BioStorage Technologies to Host Global Sample Management Benchmarking Symposium in Conjunction with Biorepositories Asia Conference
6. BioStorage Technologies Introduces New Version of Web-based Tracking and Sample Management System - ISISS®
7. BioStorage Technologies Appoints New Vice President of Global Sales
8. BioStorage Technologies Brings Together Industry Leaders for Global Sample Management Benchmarking Symposium
9. BioStorage Technologies, Inc., Welcomes Catherine Michael as Global Head of Sample Management Operations
10. BioStorage Technologies, Inc., Appoints Jeff Goddard to Global Head of Sales
11. BioStorage Technologies Takes Lead Sponsorship Role of 2nd Annual IIR Biorepositories Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/6/2016)... ... December 06, 2016 , ... The Osteoarthritis Research Society International ... Administration (FDA) to consider OA as a serious disease. As an organization of ... population of OA patients, many of whom may experience progressive disability and decreased ...
(Date:12/6/2016)... , ... December 06, 2016 ... ... Great Point Partners ("GPP") portfolio company, today announced it has acquired the ... a subsidiary of Chiltern International and focuses on clinical trial drug packaging, ...
(Date:12/6/2016)... Calif. , Dec. 6, 2016  SRI ... to $150 million from the National Institutes of ... and the Division of AIDS (NIAID-DAIDS) to support ... other non-vaccine pre-exposure (PreP) agents. Under the seven-year ... preclinical product development services for candidate HIV-prevention products ...
(Date:12/5/2016)... , Dec. 5, 2016 Axovant Sciences ... biopharmaceutical company focused on the treatment of dementia, today ... for the treatment of Alzheimer,s disease will be presented ... Meeting on Friday, December 9, 2016 in ... show results of both simple and complex measures of ...
Breaking Biology Technology:
(Date:12/6/2016)... Dec. 6, 2016 Securus Technologies, a ... solutions for public safety, investigation, corrections and monitoring, ... today a five (5) year funding commitment by ... expand the rehabilitation and reentry support to more ... Established in 2004, the Prison Entrepreneurship Program (PEP) ...
(Date:12/2/2016)... 2016 The report "Biometric Vehicle ... Technology (Iris Recognition System), Vehicle Type (Passenger Car, ... to 2021", published by MarketsandMarkets, the market is ... and is projected to grow to USD 854.8 ...      (Logo: http://photos.prnewswire.com/prnh/20160303/792302) ...
(Date:11/30/2016)... 30, 2016 Not many of us realize that we spend ? of ... we need to do it well. Inadequate sleep levels have been found to lead ... diabetes, and even cancer. Maybe now is the best time to rethink ... them to manage their sleep quality? Continue Reading ... ...
Breaking Biology News(10 mins):